About
Adiso develops novel therapies for inflammatory diseases using small molecules that modulate neutrophils and inhibit inflammasomes, alongside single strain live biotherapeutic products with novel mechanisms of action.
Explore Adiso's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.